The co-evolution of the drug industry and the regulatory agencies challenges both groups
Jan 1, 2007
By:Benjamin Locwin
How much do regulatory agencies know about nanotechnology or microfluidics? Yesterday, the answer was probably, "not much." Tomorrow, it may be "a lot." The reason is that new technologies push the agencies to expand their expertise.
 |
